These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 21610141

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Corticosteroid insensitive alveolar macrophages from asthma patients; synergistic interaction with a p38 mitogen-activated protein kinase (MAPK) inhibitor.
    Lea S, Harbron C, Khan N, Booth G, Armstrong J, Singh D.
    Br J Clin Pharmacol; 2015 May; 79(5):756-66. PubMed ID: 25358442
    [Abstract] [Full Text] [Related]

  • 3. Corticosteroid effects on COPD alveolar macrophages: dependency on cell culture methodology.
    Higham A, Lea S, Ray D, Singh D.
    J Immunol Methods; 2014 Mar; 405(100):144-53. PubMed ID: 24530567
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of lipopolysaccharide-stimulated chronic obstructive pulmonary disease macrophage inflammatory gene expression by dexamethasone and the p38 mitogen-activated protein kinase inhibitor N-cyano-N'-(2-{[8-(2,6-difluorophenyl)-4-(4-fluoro-2-methylphenyl)-7-oxo-7,8-dihydropyrido[2,3-d] pyrimidin-2-yl]amino}ethyl)guanidine (SB706504).
    Kent LM, Smyth LJ, Plumb J, Clayton CL, Fox SM, Ray DW, Farrow SN, Singh D.
    J Pharmacol Exp Ther; 2009 Feb; 328(2):458-68. PubMed ID: 19004925
    [Abstract] [Full Text] [Related]

  • 6. Reversal of corticosteroid insensitivity by p38 MAPK inhibition in peripheral blood mononuclear cells from COPD.
    Khorasani N, Baker J, Johnson M, Chung KF, Bhavsar PK.
    Int J Chron Obstruct Pulmon Dis; 2015 Feb; 10():283-91. PubMed ID: 25678784
    [Abstract] [Full Text] [Related]

  • 7. Effect of p38 MAPK inhibition on corticosteroid suppression of cytokine release in severe asthma.
    Bhavsar P, Khorasani N, Hew M, Johnson M, Chung KF.
    Eur Respir J; 2010 Apr; 35(4):750-6. PubMed ID: 19840967
    [Abstract] [Full Text] [Related]

  • 8. Resveratrol impairs the release of steroid-resistant inflammatory cytokines from human airway smooth muscle cells in chronic obstructive pulmonary disease.
    Knobloch J, Sibbing B, Jungck D, Lin Y, Urban K, Stoelben E, Strauch J, Koch A.
    J Pharmacol Exp Ther; 2010 Dec; 335(3):788-98. PubMed ID: 20801891
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the anti-inflammatory effects of Cilomilast, Budesonide and a p38 Mitogen activated protein kinase inhibitor in COPD lung tissue macrophages.
    Ratcliffe MJ, Dougall IG.
    BMC Pharmacol Toxicol; 2012 Nov 13; 13():15. PubMed ID: 23148608
    [Abstract] [Full Text] [Related]

  • 10. IFN-γ synergistically enhances LPS signalling in alveolar macrophages from COPD patients and controls by corticosteroid-resistant STAT1 activation.
    Southworth T, Metryka A, Lea S, Farrow S, Plumb J, Singh D.
    Br J Pharmacol; 2012 Aug 13; 166(7):2070-83. PubMed ID: 22352763
    [Abstract] [Full Text] [Related]

  • 11. Intrapulmonary administration of a p38 mitogen activated protein kinase inhibitor partially prevents pulmonary inflammation.
    Hoogendijk AJ, Pinhanços SS, van der Poll T, Wieland CW.
    Immunobiology; 2013 Apr 13; 218(4):435-42. PubMed ID: 22727776
    [Abstract] [Full Text] [Related]

  • 12. Glucocorticoid sensitivity of lipopolysaccharide-stimulated chronic obstructive pulmonary disease alveolar macrophages.
    Armstrong J, Sargent C, Singh D.
    Clin Exp Immunol; 2009 Oct 13; 158(1):74-83. PubMed ID: 19737233
    [Abstract] [Full Text] [Related]

  • 13. Differential anti-inflammatory effects of budesonide and a p38 MAPK inhibitor AZD7624 on COPD pulmonary cells.
    Higham A, Karur P, Jackson N, Cunoosamy DM, Jansson P, Singh D.
    Int J Chron Obstruct Pulmon Dis; 2018 Oct 13; 13():1279-1288. PubMed ID: 29719383
    [Abstract] [Full Text] [Related]

  • 14. Mechanisms of corticosteroid insensitivity in COPD alveolar macrophages exposed to NTHi.
    Khalaf RM, Lea SR, Metcalfe HJ, Singh D.
    Respir Res; 2017 Apr 18; 18(1):61. PubMed ID: 28420398
    [Abstract] [Full Text] [Related]

  • 15. Inhibitory effect of p38 mitogen-activated protein kinase inhibitors on cytokine release from human macrophages.
    Smith SJ, Fenwick PS, Nicholson AG, Kirschenbaum F, Finney-Hayward TK, Higgins LS, Giembycz MA, Barnes PJ, Donnelly LE.
    Br J Pharmacol; 2006 Oct 18; 149(4):393-404. PubMed ID: 16953188
    [Abstract] [Full Text] [Related]

  • 16. BIRB 796 enhances cytotoxicity triggered by bortezomib, heat shock protein (Hsp) 90 inhibitor, and dexamethasone via inhibition of p38 mitogen-activated protein kinase/Hsp27 pathway in multiple myeloma cell lines and inhibits paracrine tumour growth.
    Yasui H, Hideshima T, Ikeda H, Jin J, Ocio EM, Kiziltepe T, Okawa Y, Vallet S, Podar K, Ishitsuka K, Richardson PG, Pargellis C, Moss N, Raje N, Anderson KC.
    Br J Haematol; 2007 Feb 18; 136(3):414-23. PubMed ID: 17173546
    [Abstract] [Full Text] [Related]

  • 17. Inhibitors of p38 suppress cytokine production in rheumatoid arthritis synovial membranes: does variable inhibition of interleukin-6 production limit effectiveness in vivo?
    Page TH, Brown A, Timms EM, Foxwell BM, Ray KP.
    Arthritis Rheum; 2010 Nov 18; 62(11):3221-31. PubMed ID: 20589681
    [Abstract] [Full Text] [Related]

  • 18. Resveratrol impairs the release of steroid-resistant cytokines from bacterial endotoxin-exposed alveolar macrophages in chronic obstructive pulmonary disease.
    Knobloch J, Hag H, Jungck D, Urban K, Koch A.
    Basic Clin Pharmacol Toxicol; 2011 Aug 18; 109(2):138-43. PubMed ID: 21447053
    [Abstract] [Full Text] [Related]

  • 19. Dexamethasone and p38 MAPK inhibition of cytokine production from human lung fibroblasts.
    Higham A, Singh D.
    Fundam Clin Pharmacol; 2021 Aug 18; 35(4):714-724. PubMed ID: 33145838
    [Abstract] [Full Text] [Related]

  • 20. Mechanism of interleukin-13 production by granulocyte-macrophage colony-stimulating factor-dependent macrophages via protease-activated receptor-2.
    Yamaguchi R, Yamamoto T, Sakamoto A, Ishimaru Y, Narahara S, Sugiuchi H, Hirose E, Yamaguchi Y.
    Blood Cells Mol Dis; 2015 Jun 18; 55(1):21-6. PubMed ID: 25976462
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.